72
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Study of Hormone Refractory Prostate Cancer: Hospital Care and Palliative Care Resource Use at a VA Medical Center

, M.S. , R.N., , , , , & show all
Pages 849-857 | Published online: 23 Nov 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maneesha Mehra, Ying Wu & Ravinder Dhawan. (2012) Healthcare resource use in advanced prostate cancer patients treated with docetaxel. Journal of Medical Economics 15:5, pages 836-843.
Read now

Articles from other publishers (16)

MegCholack Awunti, David L. DeRemer, Sherise Rogers, Lisa Scarton, Lauren Adkins, Diana J. WIlkie & John M. Allen. (2022) A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:12, pages 1284-1296.
Crossref
Gemma Clarke, Emma Chapman, Jodie Crooks, Jonathan Koffman, Shenaz Ahmed & Michael I. Bennett. (2022) Does ethnicity affect pain management for people with advanced disease? A mixed methods cross-national systematic review of ‘very high’ Human Development Index English-speaking countries. BMC Palliative Care 21:1.
Crossref
Siwen Yin, Yong Chen, Hang Tong, Tinghao Li, Zijia Qin, Junlong Zhu & Weiyang He. (2022) PP2A promotes apoptosis and facilitates docetaxel sensitivity via the PP2A/p‑eIF4B/XIAP signaling pathway in prostate cancer. Oncology Letters 23:3.
Crossref
H. M. Westgeest, M. C. P. Kuppen, A. J. M. van den Eertwegh, R. de Wit, A. M. Bergman, R. J. A. van Moorselaar, J. L. L. M. Coenen, A. C. M. van den Bergh, D. M. Somford, N. Mehra, I. M. van Oort, K. K. H. Aben, W. R. Gerritsen & C. A. Uyl-de Groot. (2021) The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population. Prostate Cancer and Prostatic Diseases 24:3, pages 871-879.
Crossref
Juha Mehtälä, Jihong Zong, Zdravko Vassilev, Gunnar Brobert, Montse Soriano Gabarró, Pär Stattin & Houssem Khanfir. (2020) Overall survival and second primary malignancies in men with metastatic prostate cancer. PLOS ONE 15:2, pages e0227552.
Crossref
Anna Collins, Vijaya Sundararajan, Jeremy Millar, Jodie Burchell, Brian Le, Mei Krishnasamy, Sue-Anne McLachlan, Peter Hudson, Linda Mileshkin & Jennifer Philip. (2019) The trajectory of patients who die from metastatic prostate cancer: a population-based study. BJU International 123, pages 19-26.
Crossref
Chan-Kyung Jane Cho, Katherine Sunderland, Tom Pickles, Francois Bachand, Kim N. Chi & Scott Tyldesley. (2019) A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer. Practical Radiation Oncology 9:3, pages e274-e282.
Crossref
Andrew J. Robles, Jiangnan Peng, Rachel M. Hartley, Brigette Lee & Susan L. Mooberry. (2015) Melampodium leucanthum , a Source of Cytotoxic Sesquiterpenes with Antimitotic Activities . Journal of Natural Products 78:3, pages 388-395.
Crossref
Leslie Wilson, Jun Tang, Lixian Zhong, Gregory Balani, Gregory Gipson, Pin Xiang, Dawn Yu & Sandy Srinivas. (2013) New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?. Journal of Oncology Pharmacy Practice 20:6, pages 417-425.
Crossref
C. Zhang, T. Jing, F. Wang, X. Gao, C. Xu & Y. Sun. (2014) Chemotherapy plus estramustine for management of castration-resistant prostate cancer: Meta-analysis of randomized controlled trials. Actas Urológicas Españolas (English Edition) 38:3, pages 184-191.
Crossref
C. Zhang, T. Jing, F. Wang, X. Gao, C. Xu & Y. Sun. (2014) Quimioterapia con estramustina en el manejo del cáncer de próstata resistente a la castración: metaanálisis de ensayos controlados aleatorizados. Actas Urológicas Españolas 38:3, pages 184-191.
Crossref
Lixian Zhong, Vickie Pon, Sandy Srinivas, Nicole Nguyen, Meghan Frear, Sherry Kwon, Cynthia Gong, Robert Malmstrom & Leslie Wilson. (2013) Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis. PLoS ONE 8:5, pages e64275.
Crossref
Hanna A. Zaghloul & Jose R. MurilloJr.Jr.. (2012) Treatment Given Near the End of Life in Castration-Resistant Prostate Cancer. American Journal of Hospice and Palliative Medicine® 29:7, pages 536-540.
Crossref
S. J. Ramey & S. H. Chin. (2011) Disparity in Hospice Utilization by African American Patients With Cancer. American Journal of Hospice and Palliative Medicine 29:5, pages 346-354.
Crossref
David Hui, Masanori Mori, Henrique A. Parsons, Sun Hyun Kim, Zhijun Li, Shamsha Damani & Eduardo Bruera. (2012) The Lack of Standard Definitions in the Supportive and Palliative Oncology Literature. Journal of Pain and Symptom Management 43:3, pages 582-592.
Crossref
M. Kirby, C. Hirst & E. D. Crawford. (2011) Characterising the castration-resistant prostate cancer population: a systematic review. International Journal of Clinical Practice 65:11, pages 1180-1192.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.